Welcome to our dedicated page for Corteva news (Ticker: CTVA), a resource for investors and traders seeking the latest updates and insights on Corteva stock.
Corteva Inc (NYSE: CTVA), a global leader in agriscience innovation, provides this centralized hub for investors and agricultural professionals to track essential company developments. Access verified press releases and news coverage spanning Corteva's seed technology advancements, crop protection solutions, and digital agriculture initiatives.
This resource delivers timely updates on earnings reports, product launches, sustainability efforts, and strategic partnerships. Users gain insights into operational milestones across Corteva's core business segments while maintaining compliance with financial disclosure standards.
Key content categories include regulatory filings, R&D breakthroughs, market expansion announcements, and executive leadership updates. All materials are curated to support informed decision-making without speculative commentary.
Bookmark this page for direct access to Corteva's official communications and third-party analysis of agricultural technology trends impacting the company's performance.
Corteva (NYSE: CTVA) and bp announced their intent to form a joint venture focused on producing crop-based biofuel feedstocks for sustainable aviation fuel (SAF). The partnership aims to deliver one million metric tons of biofuel feedstocks annually by mid-2030s. Corteva will contract farmers in North and South America, and Europe to grow mustard seed, sunflower, and canola feedstocks. The initiative aligns with EU's SAF mandate requiring 20% SAF by 2035 and 70% by 2050 at EU airports. The companies plan to finalize agreements in 2025 with operations starting later that year.
Corteva (NYSE: CTVA) reported Q3 2024 financial results showing declining performance. Net sales decreased 10% to $2.33B, with a net loss of $519M. Year-to-date net sales declined 4% to $12.93B with income of $913M. Seed sales showed price gains but volume declines due to reduced corn planted area in Latin America. Crop Protection sales decreased 9% due to weather and destocking impacts.
The company updated its 2024 guidance, expecting net sales of $17.0-17.2B and Operating EBITDA of $3.35-3.45B. For 2025, preliminary outlook projects net sales of $17.3-17.7B and Operating EBITDA of $3.6-4.0B.
Corteva (NYSE: CTVA) has announced its Board of Directors approved a quarterly common stock dividend of $0.17 per share, payable December 16, 2024, to shareholders of record on December 2, 2024. Additionally, EIDP, a wholly owned subsidiary of Corteva, declared preferred stock dividends of $1.12-1/2 per share on the $4.50 series and $0.87-1/2 per share on the $3.50 series, both payable January 23, 2025, to stockholders of record on January 8, 2025.
Corteva (NYSE: CTVA) has appointed Judd O'Connor as the new Executive Vice President (EVP) of its Seed Business Unit, effective December 1, 2024. O'Connor, a 25-year veteran of Corteva and its heritage companies, will succeed Tim Glenn, who will serve as a Strategic Advisor until his retirement in Q1 2025. O'Connor previously served as President of Corteva's North America business and has extensive global experience, including roles in Latin America and leading integration efforts during the Dow-DuPont merger.
CEO Chuck Magro praised O'Connor's deep customer insights and operational expertise. O'Connor expressed enthusiasm for leading the seed business and leveraging technology to support farmers. Glenn, who has served the company for over 30 years, expressed pride in the Seed business's global impact and confidence in O'Connor's leadership.
Micropep Technologies, the global leader in micropeptide crop protection technologies, has successfully closed its Series B funding round with an additional $11 million commitment. This investment, from new investors Corteva Inc. and Sparkfood SA, along with existing investors, brings the total Series B round to $40 million and elevates the company's total funding to over $60 million.
The capital will support Micropep's pipeline of sustainable micropeptide solutions using its proprietary discovery platform, Krisalix™. This platform allows researchers to discover new micropeptide molecules efficiently for more effective and environmentally friendly crop protection. Micropeptides offer novel crop protection options for farmers, combining new modes of action, safety, strong efficacy, and affordability.
This funding will extend Micropep's market position, strengthen partnerships, and build new relationships within the industry, ultimately bringing micropeptide-based products to farmers worldwide.
Corteva, Inc. (NYSE: CTVA) has announced that its Chief Executive Officer, Chuck Magro, will be speaking at the 2024 BMO Ag-Apalooza event. The presentation is scheduled for Tuesday, September 24, 2024, at 12:00 p.m. Eastern Time.
The event will be webcast live and can be accessed through the Corteva Investor Relations website. For those unable to attend the live presentation, a replay will be made available 24 hours after the event and will remain accessible until October 24, 2024.
This presentation provides an opportunity for investors and interested parties to gain insights into Corteva's current operations and future strategies directly from the company's top executive.
Corteva (NYSE: CTVA) and Pairwise have announced a strategic collaboration to accelerate gene editing solutions in agriculture. The partnership includes:
- Corteva's $25 million equity investment in Pairwise through Corteva Catalyst
- Formation of a five-year joint venture to develop advanced gene edited technologies
- Focus on increasing crop yield and climate resilience
The collaboration aims to leverage both companies' gene editing capabilities to create crops more resilient to extreme weather and climate change. Pairwise's Fulcrum™ Platform, which includes proprietary gene editing tools, will play a key role in developing new plant varieties faster than conventional breeding methods.
Corteva (NYSE: CTVA) has announced an Investor Day scheduled for November 19, 2024, from 9:00 a.m. to 12:30 p.m. Eastern Time. The event will feature presentations by CEO Chuck Magro and the senior leadership team, focusing on the company's strategy, technology pipeline, and financial framework.
Investors can access the event through a webcast by registering on the Investor Events and Presentations website. The presentations will be available for replay until November 19, 2025, providing an extended opportunity for stakeholders to review the company's plans and projections.
This Investor Day represents a significant opportunity for Corteva to showcase its roadmap for growth and engage with the investment community, potentially impacting the company's stock performance and market perception.
Corteva (NYSE: CTVA) has announced the dates for its third quarter 2024 earnings release and webcast. The company will release its Q3 2024 earnings on Wednesday, November 6, 2024, after the stock market closes. The earnings will be available via press release and on the company's website. A live webcast presentation of the earnings will take place on Thursday, November 7, 2024, at 9:00 a.m. Eastern Time. An accompanying slide presentation will be posted on Corteva's Investor Events and Presentations page. Investors can access a replay of the webcast on the same page until November 7, 2025.
Corteva (NYSE: CTVA) reported solid first half 2024 results, with the Seed business driving performance. Key highlights include:
- Q2 2024: Net sales up 1% to $6.11B, Income from continuing operations up 20% to $1.06B
- 1H 2024: Net sales down 3% to $10.60B, Income from continuing operations down 4% to $1.43B
- Seed net sales grew 2%, organic sales up 4%
- Crop Protection net sales and organic sales both decreased 11%
Corteva updated its full-year 2024 guidance:
- Net sales: $17.2B to $17.5B
- Operating EBITDA: $3.4B to $3.6B
- Operating EPS: $2.60 to $2.80
- Free Cash Flow: $1.5B to $2.0B
The company plans to repurchase approximately $1.0B in shares in 2024.
FAQ
What is the current stock price of Corteva (CTVA)?
What is the market cap of Corteva (CTVA)?
